journal article·2024-04Open access

Pro‐Regenerative Glycopeptide Hydrogel Activates Type 2 Immune Response for Wound Healing via Macrophage‐T Cell Crosstalk

Jingrong Wang, Xiang Liu, Yaping Wang, Yushan Zhang, Rui Gao, Yu Gao, Pengxu Kong, Yini Huangfu, Chuangnian Zhang, Zujian Feng, Pingsheng Huang, Pengxiang Yang, Weiwei Wang

Advanced Functional Materials· Volume 34· Issue 16

Abstract

Abstract Immunomodulatory biomaterials are increasingly used in regenerative medicine. Biomimetic glycopeptide hydrogel is found to accelerate cutaneous wound healing by inducing macrophage M2‐type polarization, however, it is unclear whether this will possibly orchestrate a pro‐regenerative T cell immunity. Here the aim of this study is to elucidate the reparative T‐cell immune response in tissue regeneration by augmenting macrophage‐T cell crosstalk with a novel immunomodulatory glycopeptide hydrogel (termed as GRKgel) self‐assembled by mannose receptor‐binding glucomannan (GM) chemically grafted with RADA16‐conjugated T‐cell epitope. The glycopeptide can be phagocytized and processed by macrophages, which then presents peptides to naïve T cells and polarizes them into T helper 2 (TH2) cells through IL‐4‐dependent STAT6/GATA3 or c‐Maf pathways. Strikingly, full‐thickness skin wound repair in mice indicates a superior efficacy of GRKgel on restoring the pathological structure and hair follicle by provoking TH2 immune response, increasing the residence of M2 macrophages, as well as promoting angiogenesis at the local tissue environment. Furthermore, genomics results illustrates the role of GRKgel serving as an immunomodulatory niche, orchestrating immune cell crosstalk and promoting extracellular matrix (ECM) reconstruction. Collectively, this study highlights the significance of crosstalk between immune cells in evoking pro‐healing T‐cell immunity, providing a promising drug‐/cytokine‐free strategy for endogenous tissue regeneration.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Wound Healing and Treatments · Peptidase Inhibition and Analysis · Antimicrobial Peptides and Activities

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Advanced Medical Materials and Devices Institute of Biomedical Engineering Chinese Academy of Medical Science & Peking Union Medical College Tianjin 300192 China

Department of Polymer Science and Engineering Key Laboratory of Systems Bioengineering (Ministry of Education) School of Chemical Engineering and Technology Tianjin University Tianjin 300072 China

Medical 3D Printing Center The First Affiliated Hospital of Zhengzhou University Zhengzhou 450000 China

Department of Structural Heart Disease Fuwai Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100037 China

Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education Co‐innovation Center of Neuroregeneration Nantong University Nantong 226001 China

Funding

Fundamental Research Funds for the Central Universities

References (64)

Show source-provided references
1. 10.1038/s41590-022-01173-710.1038/s41590-022-01173-7 ↗
2. 10.1038/nri.2016.5110.1038/nri.2016.51 ↗
3. Rousselle P. · Matrix Biol. · 2019 · 12 · 75
4. 10.1152/physrev.2003.83.3.83510.1152/physrev.2003.83.3.835 ↗
5. 10.1016/j.molmed.2020.07.00910.1016/j.molmed.2020.07.009 ↗
6. 10.1016/j.addr.2021.11391310.1016/j.addr.2021.113913 ↗
7. 10.1186/s40779-022-00426-810.1186/s40779-022-00426-8 ↗
8. 10.1021/acs.chemrev.0c0089510.1021/acs.chemrev.0c00895 ↗
9. 10.1002/adma.20210017610.1002/adma.202100176 ↗
10. 10.1021/acs.accounts.0c0034110.1021/acs.accounts.0c00341 ↗
11. 10.1002/adhm.20220167110.1002/adhm.202201671 ↗
12. 10.7150/thno.2738510.7150/thno.27385 ↗
13. 10.1002/smll.20210783810.1002/smll.202107838 ↗
14. 10.1002/adma.20200417210.1002/adma.202004172 ↗
15. 10.1002/adfm.20200645410.1002/adfm.202006454 ↗
16. 10.1126/sciadv.abn700610.1126/sciadv.abn7006 ↗
17. 10.1002/advs.20230124410.1002/advs.202301244 ↗
18. 10.1016/j.actbio.2021.02.02310.1016/j.actbio.2021.02.023 ↗
19. 10.1126/science.aad927210.1126/science.aad9272 ↗
20. 10.1021/acsnano.7b0897610.1021/acsnano.7b08976 ↗
21. 10.1126/science.106963910.1126/science.1069639 ↗
22. 10.1038/s41392-020-00455-610.1038/s41392-020-00455-6 ↗
23. 10.1038/s41590-022-01387-910.1038/s41590-022-01387-9 ↗
24. 10.1038/s41586-022-05028-x10.1038/s41586-022-05028-x ↗
25. 10.1038/nri.2017.9010.1038/nri.2017.90 ↗
26. 10.1172/JCI5964310.1172/JCI59643 ↗
27. 10.1016/j.actbio.2017.01.05610.1016/j.actbio.2017.01.056 ↗
28. 10.1038/s41423-020-00541-310.1038/s41423-020-00541-3 ↗
29. 10.1126/science.aam792810.1126/science.aam7928 ↗
30. 10.1161/CIRCRESAHA.118.31466910.1161/CIRCRESAHA.118.314669 ↗
31. 10.1039/D0BM01747G10.1039/D0BM01747G ↗
32. Zhang Y. S. · Science · 2017 · 356
33. 10.1039/D0BM00055H10.1039/D0BM00055H ↗
34. 10.1002/adhm.20210023410.1002/adhm.202100234 ↗
35. 10.1039/C6CS00052E10.1039/C6CS00052E ↗
36. 10.1016/j.tibtech.2019.07.01410.1016/j.tibtech.2019.07.014 ↗
37. 10.1146/annurev-chembioeng-061010-11425710.1146/annurev-chembioeng-061010-114257 ↗
38. 10.1016/j.addr.2015.11.00110.1016/j.addr.2015.11.001 ↗
39. 10.1016/j.carbpol.2019.11519910.1016/j.carbpol.2019.115199 ↗
40. 10.1038/nrurol.2012.1910.1038/nrurol.2012.19 ↗
41. 10.1016/j.ijbiomac.2016.02.05810.1016/j.ijbiomac.2016.02.058 ↗
42. 10.1016/j.biomaterials.2022.12153810.1016/j.biomaterials.2022.121538 ↗
43. 10.1016/j.biomaterials.2021.12082510.1016/j.biomaterials.2021.120825 ↗
44. 10.1021/acs.chemrev.0c0069010.1021/acs.chemrev.0c00690 ↗
45. 10.1021/acsami.9b1023910.1021/acsami.9b10239 ↗
46. 10.1002/jbm.b.3452410.1002/jbm.b.34524 ↗
47. 10.1002/smll.20200633510.1002/smll.202006335 ↗
48. 10.1039/b811392k10.1039/b811392k ↗
49. 10.1038/nbt105510.1038/nbt1055 ↗
50. 10.1002/advs.20230124410.1002/advs.202301244 ↗
51. 10.1098/rsob.20022310.1098/rsob.200223 ↗
52. 10.1038/s41563-020-00844-w10.1038/s41563-020-00844-w ↗
53. 10.1002/eji.20194816110.1002/eji.201948161 ↗
54. 10.1016/j.cyto.2015.05.01010.1016/j.cyto.2015.05.010 ↗
55. 10.1146/annurev-immunol-051116-05235010.1146/annurev-immunol-051116-052350 ↗
56. 10.1182/blood-2004-10-407410.1182/blood-2004-10-4074 ↗
57. 10.1084/jem.188.10.185910.1084/jem.188.10.1859 ↗
58. 10.1038/s41423-018-0004-410.1038/s41423-018-0004-4 ↗
59. 10.1016/j.immuni.2019.02.01310.1016/j.immuni.2019.02.013 ↗
60. 10.1126/scitranslmed.300933710.1126/scitranslmed.3009337 ↗
61. 10.1189/jlb.4MR0316-102R10.1189/jlb.4MR0316-102R ↗
62. 10.1042/CS2014071410.1042/CS20140714 ↗
63. 10.1038/nm0603-68510.1038/nm0603-685 ↗
64. 10.1007/978-1-4939-2929-0_610.1007/978-1-4939-2929-0_6 ↗